Why the study?
Does maintenance chemotherapy improve survival in patients with angiosarcoma?
Does maintenance chemotherapy improve survival in patients with angiosarcoma?
Maintenance chemotherapy significantly prolonged survival in a retrospective cohort of angiosarcoma patients, highlighted by a case of 200-month survival with sequential chemotherapy changes.
Answers are grounded in this paper and cite their sources.
Maintenance chemotherapy may prolong survival in angiosarcoma; hypothesis-generating and should not yet change practice.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Kamada et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: